美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

312.51

-7.2371-2.26%

涨家数：1

跌家数：5

平家数：- -

市盈率：- -

高：320.95

开：316.58

低：306.00

收：319.74

数据加载中...

总览新闻资讯

币安Alpha上新:Bluefin (BLUE)

Binance Alpha上线BLUE

Sangamo Therapeutics, Inc.股价重挫39.90% 市值跌4104.19万美元

Editas 医药公司公布截至 3 月 31 日的季度业绩 - 收益摘要

蓝鸟生物盘中异动股价大跌5.00%

Editas Medicine, Inc.盘中异动早盘股价大涨18.30%报1.72美元

Crispr Therapeutics Ag盘中异动股价大涨5.22%

Intellia Therapeutics, Inc.盘中异动急速上涨5.30%

Sangamo Therapeutics, Inc.盘中异动急速拉升5.43%报0.738美元

蓝鸟生物盘中异动急速下挫5.08%

Intellia Therapeutics, Inc.盘中异动快速上涨5.07%报8.70美元

Beam Therapeutics Inc.盘中异动早盘快速拉升5.16%

Editas Medicine, Inc.盘中异动大幅上涨5.76%报1.47美元

Crispr Therapeutics Ag盘中异动急速拉升5.05%

BUZZ-Intellia Therapeutics 因第一季度亏损收窄而上涨

Editas Medicine, Inc.盘中异动早盘急速上涨5.26%报1.40美元

Intellia Therapeutics, Inc.盘中异动股价大涨10.97%

加密市场板块部分上涨，BTC连涨两日，一度涨破9.8万美元

蓝鸟生物盘中异动股价大跌5.47%报3.63美元

Crispr Therapeutics Ag盘中异动快速跳水5.01%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":312.50595,"timestamp":1747166399999,"preClose":319.743,"halted":0,"volume":27771056,"delay":0,"changeRate":-0.022634,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-7.237061,"latestTime":"05-13 16:00:00 EDT","open":316.5849,"high":320.95328,"low":306.00146,"amount":147678296.961514,"amplitude":0.046762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747229400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.60439,"peRate":-3.303227,"turnoverRate":0.047278,"increases":1,"decrements":5,"flats":0,"marketCap":6152642156,"floatMarketCap":5919535678},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":320.95328,"amplitude":0.046762,"preClose":319.743,"low":306.00146,"pbRate":"1.60439","latestPrice":312.50595,"volume":27771056,"delay":0,"open":316.5849,"prevYearClose":376.62552,"prevWeekClose":303.7772,"prevMonthClose":336.3879,"prevQuarterClose":297.7814,"fiveDayClose":280.0407,"twentyDayClose":314.6917,"sixtyDayClose":453.9017,"secType":"PLATE","market":"US","turnoverRate":0.047278,"peRate":-3.303227,"marketCap":6152642156,"floatMarketCap":5919535678,"timestamp":1747166399999,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":1,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535009723","title":"币安Alpha上新:Bluefin (BLUE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535009723","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535009723?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 15:30","pubTimestamp":1747207854,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 币安 Alpha 上新：\nBluefin （BLUE）\n合约： 0xe1b45a0e641b9955a20aa0ad1c1f4ad86aad8afb07296d4085e349a50e90bdca::blue::BLUE\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/430637?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK4556","BK4578","BLUE","BK4139"],"gpt_icon":0},{"id":"2535309019","title":"Binance Alpha上线BLUE","url":"https://stock-news.laohu8.com/highlight/detail?id=2535309019","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535309019?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 15:30","pubTimestamp":1747207800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/293833","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BLUE","BK4556","BK4578","BK4139"],"gpt_icon":0},{"id":"2535705032","title":"Sangamo Therapeutics, Inc.股价重挫39.90% 市值跌4104.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535705032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535705032?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 21:32","pubTimestamp":1747143136,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日21时32分，Sangamo Therapeutics, Inc.股票出现波动，股价大幅下跌39.90%。截至发稿，该股报0.449美元/股，成交量312.285万股，换手率1.36%，振幅4.18%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513213225a47cd07e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513213225a47cd07e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LENZ","BK4539","BK4007","BK4139","SGMO"],"gpt_icon":0},{"id":"2535780746","title":"Editas 医药公司公布截至 3 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780746","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780746?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 05:37","pubTimestamp":1747085864,"startTime":"0","endTime":"0","summary":"Editas 医药公司公布截至 3 月 31 日的季度业绩 - 收益摘要Editas Medicine Inc EDIT.OQ 公布，在截至 3 月 31 日的季度调整后每股亏损 92 美分，低于去年同期的每股收益-76 美分。11 位分析师对该季度的平均预期是每股亏损 59 美分。Editas Medicine Inc 公布的本季度每股收益为亏损 92 美分。该公司当季亏损 7609 万美元。Editas Medicine Inc 本季度股价上涨了 25.0%，今年迄今为止上涨了 14.2%。华尔街对 Editas Medicine Inc 的 12 个月目标价中位数为 3.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL4S3RK1XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2535789503","title":"蓝鸟生物盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789503?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 03:52","pubTimestamp":1747079546,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日03时52分，蓝鸟生物股票出现异动，股价大幅下跌5.00%。截至发稿，该股报3.33美元/股，成交量73.0643万股，换手率7.46%，振幅6.57%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为3.60%。其相关个股中，Cytomx Therapeutics, Inc.、Klotho Neurosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1151.02%、134.51%、72.32%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cytomx Therapeutics, Inc.，振幅分别为122.88%、90.83%、57.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051303522694f4c295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051303522694f4c295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BLUE","BK4556","BK4139"],"gpt_icon":0},{"id":"2534527524","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨18.30%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534527524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534527524?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:41","pubTimestamp":1747057292,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时41分，Editas Medicine, Inc.股票出现波动，股价急速拉升18.30%。截至发稿，该股报1.72美元/股，成交量50.0156万股，换手率0.60%，振幅13.79%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为2.95%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214132a47b7af2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214132a47b7af2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2534720861","title":"Crispr Therapeutics Ag盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534720861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534720861?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:34","pubTimestamp":1747056893,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时34分，Crispr Therapeutics Ag股票出现波动，股价大幅拉升5.22%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为1.87%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221345394f48251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221345394f48251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4611","BK4007","BK4539","BK4588","LENZ","LU1861558580.USD","BK4139","CRSP","LU1861559042.SGD","BK4556"],"gpt_icon":0},{"id":"2534208760","title":"Intellia Therapeutics, Inc.盘中异动 急速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534208760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534208760?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:33","pubTimestamp":1747056811,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时33分，Intellia Therapeutics, Inc.股票出现异动，股价大幅上涨5.30%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213331aa2c8af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213331aa2c8af6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1861558580.USD","BK4556","BK4588","BK4535","BK4539","BK4007","BK4585","NTLA","LU1861559042.SGD","LENZ"],"gpt_icon":0},{"id":"2534271300","title":"Sangamo Therapeutics, Inc.盘中异动 急速拉升5.43%报0.738美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534271300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534271300?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:32","pubTimestamp":1747056771,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Sangamo Therapeutics, Inc.股票出现波动，股价急速上涨5.43%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221325197574479&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221325197574479&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","SGMO","LENZ","BK4556"],"gpt_icon":0},{"id":"2534578714","title":"蓝鸟生物盘中异动 急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534578714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534578714?lang=zh_cn&edition=fundamental","pubTime":"2025-05-10 03:11","pubTimestamp":1746817872,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日03时11分，蓝鸟生物股票出现异动，股价快速下跌5.08%。截至发稿，该股报3.52美元/股，成交量25.7205万股，换手率2.63%，振幅6.87%。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，80%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为3.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510031113aa2c89aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510031113aa2c89aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4578","BLUE"],"gpt_icon":0},{"id":"2534480404","title":"Intellia Therapeutics, Inc.盘中异动 快速上涨5.07%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534480404?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 21:45","pubTimestamp":1746798339,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时45分，Intellia Therapeutics, Inc.股票出现异动，股价急速上涨5.07%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214540aa2c890b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214540aa2c890b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","BK4585","NTLA","BK4539","BK4535","LU1861559042.SGD","BK4007","LENZ","BK4139","BK4556","BK4588"],"gpt_icon":0},{"id":"2534304480","title":"Beam Therapeutics Inc.盘中异动 早盘快速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534304480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534304480?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 21:34","pubTimestamp":1746797671,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时34分，Beam Therapeutics Inc.股票出现异动，股价急速上涨5.16%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。该信息摘要如下：巴克莱：维持Beam Therapeutics评级，由持股观望调整至持股观望评级, 目标价由31.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921343294f1d5a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921343294f1d5a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4007","BK4539","BK4556","LENZ","BEAM","BK4588","BK4139","BK4535","BK4585","BK4611"],"gpt_icon":0},{"id":"2534435697","title":"Editas Medicine, Inc.盘中异动 大幅上涨5.76%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534435697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534435697?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 21:34","pubTimestamp":1746797669,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时34分，Editas Medicine, Inc.股票出现波动，股价大幅拉升5.76%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、艾切托涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为473.77%、117.19%、11.50%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Protalix Biotherapeutics, Inc. 、Vor Biopharma Inc.，振幅分别为76.90%、15.22%、13.63%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921342994f1d5a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921342994f1d5a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2533153510","title":"Crispr Therapeutics Ag盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533153510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533153510?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 23:29","pubTimestamp":1746718144,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时29分，Crispr Therapeutics Ag股票出现异动，股价急速拉升5.05%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为2.74%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232904aa2c87bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232904aa2c87bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4007","CRSP","BK4556","LU1861559042.SGD","BK4611","BK4585","LU1861558580.USD","LENZ"],"gpt_icon":0},{"id":"2533341132","title":"BUZZ-Intellia Therapeutics 因第一季度亏损收窄而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2533341132","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533341132?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 22:43","pubTimestamp":1746715416,"startTime":"0","endTime":"0","summary":"BUZZ-Intellia Therapeutics 因第一季度亏损收窄而上涨5月8日 - ** 基因编辑公司Intellia Therapeutics NTLA.O股价上涨3.4%至7.54美元 ** NTLA报告第一季度每股净亏损1.10美元，比去年同期的净亏损1.12美元有所收窄 ** 第一季度合作收入为 1663 万美元，去年同期为 2890 万美元 ** 公司表示，截至3月31日，公司拥有现金及现金等价物7.071亿美元，预计到2027年上半年还将继续运营 ** 包括本交易日的走势在内，该股今年累计下跌 35.4(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4T3RG24D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4535","LU1861558580.USD","BK4139","LU1861559042.SGD","BK4556","NTLA","BK4585"],"gpt_icon":0},{"id":"2533598132","title":"Editas Medicine, Inc.盘中异动 早盘急速上涨5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533598132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533598132?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 22:39","pubTimestamp":1746715180,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时39分，Editas Medicine, Inc.股票出现波动，股价急速上涨5.26%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为2.97%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050822394097535879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050822394097535879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2533136958","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨10.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533136958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533136958?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 21:32","pubTimestamp":1746711130,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时32分，Intellia Therapeutics, Inc.股票出现异动，股价快速上涨10.97%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213210a6d7c3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213210a6d7c3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861559042.SGD","LENZ","BK4585","BK4139","BK4556","NTLA","BK4588","BK4535","LU1861558580.USD","BK4007"],"gpt_icon":0},{"id":"2533721917","title":"加密市场板块部分上涨，BTC连涨两日，一度涨破9.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533721917","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533721917?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 11:03","pubTimestamp":1746673399,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 根据 SoSoValue 数据，加密市场板块部分上涨，Bitcoin（BTC）连涨两日，24 小时上涨 0.85%，最高涨至 9.8 万美元上方。Ethereum（ETH）窄幅震荡，24 小时下跌 0.31%，但仍维持在 1800 美元左右。此外，Layer2 板块上涨 1.49%，板块内，Celestia（TIA）、Stacks（STX）分别上涨 3.76%、8.12%。GameFi 板块上涨 1.15%，Decentraland（MANA）、Beam（BEAM）分别上涨 3.15%、5.53%。\n与此同时，反映板块历史行情的加密板块指数显示，ssiGameFi、ssiLayer2 指数 24 小时分别上涨 1.61%、1.46%。\n其他板块方面，Meme 板块 24 小时上涨 0.84%，其中，Popcat（POPCAT）上涨 11.75%，Mog Coin（MOG）上涨 36.60%；Layer1 板块上涨 0.34%，DeFi 板块上涨 0.19%，板块内，Maker（MKR）上涨 4.34%；PayFi 板块下跌 0.07%，但 Bitcoin Cash（BCH）、Safe（SAFE）分别逆势上涨 6.51%、25.10%；CeFi 板块下跌 0.20%。\n此外，AI 板块下跌 1.21%，但 KAITO 依旧坚挺，连续两日上涨，盘中冲高 26.28%。\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/429868?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BEAM","SAFE","03009","BK4611","BK4207","IBIT","03439","ETH","QETH","09009","BK4535","BK4594","CETH","ETH.USD.HKCC","03179","09439","BTCmain","IE00B19Z9P08.USD","MKR.USD.CC","BK4588","03008","MANA","BTC.USD.CC","BCH","BK4139","09179","09046","ETH.USD.CC","BK4170","09042","09008","BTC.USD.HKCC","03046","BTC","FETH","83042","BK4234","ETHV","STX","03042","EZET","LDO.USD.HKCC","IE00B19Z9Z06.USD","XBTmain","BK4084","BK4601","BK4585","BK4556","MKR.USD.HKCC","BK1611"],"gpt_icon":0},{"id":"2533963403","title":"蓝鸟生物盘中异动 股价大跌5.47%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533963403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533963403?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 03:28","pubTimestamp":1746646131,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日03时28分，蓝鸟生物股票出现异动，股价快速下跌5.47%。截至发稿，该股报3.63美元/股，成交量9.7974万股，换手率1.00%，振幅5.21%。蓝鸟生物股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Zyversa Therapeutics, Inc.、Theriva Biologics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1810.67%、1633.53%、230.10%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Dermata Therapeutics Inc C/Wts ，振幅分别为130.71%、96.35%、91.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050803285194ef8d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050803285194ef8d95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4556","BLUE","BK4139"],"gpt_icon":0},{"id":"2533512316","title":"Crispr Therapeutics Ag盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533512316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533512316?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 23:49","pubTimestamp":1746546566,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时49分，Crispr Therapeutics Ag股票出现异动，股价急速跳水5.01%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为4.90%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062349269750daee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062349269750daee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","LU1861559042.SGD","BK4007","BK4139","BK4611","BK4585","BK4588","CRSP","LU1861558580.USD","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}